Purpose of Review
Recent genetic findings have identified new targets of investigation in the field of interstitial lung diseases and have the potential to change clinical care.
Recent Findings
These findings implicate abnormalities in (1) host defense, (2) cell-cell adhesion, and (3) aging and senescence in the pathophysiology of pulmonary fibrosis. At least one common genetic variant strongly associated with pulmonary fibrosis appears to have prognostic implications for patients.
Summary
The inherited risk for pulmonary fibrosis is substantial, and recent data suggests that genetic risk for familial and sporadic forms of the disease are similar. Further characterization of the genetic risk will influence clinical practice in terms of categorization, diagnosis, and screening of individuals for this disease.